Results 191 to 200 of about 519,396 (228)

Intrahepatic cholestasis of pregnancy associated with azathioprine: first quantitative disproportionality analysis using the FDA adverse event reporting system. [PDF]

J Pharm Pharm Sci
Kwon Y, Lee N, Kim Y.
europepmc   +1 more source

A New Prescription for America\u27s Medical Liability System [PDF]

, 2006
Barringer, Paul J., III
core   +1 more source

Safety profile of metformin in adolescents with type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System. [PDF]

PLoS One
Peng M, Shen P, Joung KI, Kim KJ.
europepmc   +1 more source

Real-world safety profile of sonidegib: a disproportionality analysis based on the FDA adverse event reporting system. [PDF]

Front Oncol
Zhao K, Li Q, Qin M, Xiao S, Li J, Liu J.   +5 more
europepmc   +1 more source

Table 4_Arrhythmic events pertinent with antidepressants: a Bayesian disproportional analysis mining the FDA Adverse Event Reporting System database.pdf

Shan Cao (5077988), Zhuoshan Huang (16536851), Wenjie Yang (2993460), Saijia Yang (22328032), Xi Chen (35903), Xujing Xie (13236219)   +5 more
openalex   +1 more source

Response to FDA Adverse Event Reporting System (FAERS) Essentials: A Reflection on Study Conception. [PDF]

Clin Pharmacol Ther
Reyes M, Potter E, Dal Pan G.
europepmc   +1 more source

Text Mining of Symptom Descriptions in the Vaccine Adverse Event Reporting System for Human Papillomavirus Vaccination. [PDF]

Cureus
Shiota K, Horibe M, Ino Y, Iwata M, Tanaka H, Kitamura M, Iguchi K, Nakamura M.   +7 more
europepmc   +1 more source

Safety assessment of ustekinumab in inflammatory bowel disease: a real-world analysis based on the FDA adverse event reporting system (FAERS). [PDF]

Eur J Med Res
Xu L, Huang Z, Chen G, Sun C, Yu Y, Gao S.   +5 more
europepmc   +1 more source

Neurological adverse events of ROS1 inhibitors for non-small cell lung cancer: data from the FDA adverse event reporting system. [PDF]

Front Neurol
Wei X, Lai Q, Zheng L.
europepmc   +1 more source